Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |